Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene - PubMed (original) (raw)
Affiliations
- PMID: 2085463
Comparative Study
Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene
A Iyer et al. Cell Growth Differ. 1990 Feb.
Abstract
A 6.7-kilobase met complementary DNA (cDNA) was isolated from a pcD cDNA library prepared from C3H mouse fibroblast cell line polyadenylated RNA. Sequence analysis of 6.7-kilobase met cDNA insert revealed that it contained the entire open reading frame and shared an overall homology of 88.1% with the human met gene. Using the mouse met cDNA as probe, high levels of met expression were observed in the kidney, brain, lung, skin, and embryonic tissue as well as in several factor responsive mouse myeloid cell lines. Under SV40 promoter control, the mouse met protooncogene cDNA in the pCD vector was able to transform NIH 3T3 cells. These transformed cells possess multiple copies of mouse met cDNA and exhibit properties of malignant cells, including growth in soft agar and induction of tumors in nude mice. Tumor explant cell lines analyzed by Western blot also reveal the presence of high levels of Mr 170,000 and 140,000 met protein product(s).
Similar articles
- Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor.
Rong S, Oskarsson M, Faletto D, Tsarfaty I, Resau JH, Nakamura T, Rosen E, Hopkins RF 3rd, Vande Woude GF. Rong S, et al. Cell Growth Differ. 1993 Jul;4(7):563-9. Cell Growth Differ. 1993. PMID: 8398896 - Hepatocyte growth factor transforms immortalized mouse liver epithelial cells.
Kanda H, Tajima H, Lee GH, Nomura K, Ohtake K, Matsumoto K, Nakamura T, Kitagawa T. Kanda H, et al. Oncogene. 1993 Nov;8(11):3047-53. Oncogene. 1993. PMID: 8414505 - Selection for transformation and met protooncogene amplification in NIH 3T3 fibroblasts using tumor necrosis factor alpha.
Hudziak RM, Lewis GD, Holmes WE, Ullrich A, Shepard HM. Hudziak RM, et al. Cell Growth Differ. 1990 Mar;1(3):129-34. Cell Growth Differ. 1990. PMID: 2078501 - Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells.
Guo XJ, Chambers AF, Parfett CL, Waterhouse P, Murphy LC, Reid RE, Craig AM, Edwards DR, Denhardt DT. Guo XJ, et al. Cell Growth Differ. 1990 Jul;1(7):333-8. Cell Growth Differ. 1990. PMID: 2177633 - The human met oncogene is a member of the tyrosine kinase family.
Gonzatti-Haces M, Park M, Dean M, Blair DG, Vande Woude GF. Gonzatti-Haces M, et al. Princess Takamatsu Symp. 1986;17:221-32. Princess Takamatsu Symp. 1986. PMID: 3332011 Review.
Cited by
- Therapeutic advances of targeting receptor tyrosine kinases in cancer.
Tomuleasa C, Tigu AB, Munteanu R, Moldovan CS, Kegyes D, Onaciu A, Gulei D, Ghiaur G, Einsele H, Croce CM. Tomuleasa C, et al. Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w. Signal Transduct Target Ther. 2024. PMID: 39138146 Free PMC article. Review. - A single-cell transcriptomic and anatomic atlas of mouse dorsal raphe Pet1 neurons.
Okaty BW, Sturrock N, Escobedo Lozoya Y, Chang Y, Senft RA, Lyon KA, Alekseyenko OV, Dymecki SM. Okaty BW, et al. Elife. 2020 Jun 22;9:e55523. doi: 10.7554/eLife.55523. Elife. 2020. PMID: 32568072 Free PMC article. - The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer.
Moran-Jones K. Moran-Jones K. Mol Diagn Ther. 2016 Jun;20(3):199-212. doi: 10.1007/s40291-016-0201-8. Mol Diagn Ther. 2016. PMID: 27139908 Review. - Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.
Li S, Ling C, Zhong L, Li M, Su Q, He R, Tang Q, Greiner DL, Shultz LD, Brehm MA, Flotte TR, Mueller C, Srivastava A, Gao G. Li S, et al. Mol Ther. 2015 Dec;23(12):1867-76. doi: 10.1038/mt.2015.174. Epub 2015 Sep 25. Mol Ther. 2015. PMID: 26403887 Free PMC article. - The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical Aspects.
Medová M, Aebersold DM, Zimmer Y. Medová M, et al. Cancers (Basel). 2013 Dec 19;6(1):1-27. doi: 10.3390/cancers6010001. Cancers (Basel). 2013. PMID: 24378750 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous